kabutan

Fuso Pharmaceutical Industries,Ltd.(4538) Summary

4538
TSE Prime
Fuso Pharmaceutical Industries,Ltd.
2,256
JPY
-6
(-0.27%)
Jan 29, 3:30 pm JST
14.74
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
8.3
PBR
0.57
Yield
3.99%
Margin Trading Ratio
22.59
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
2,262 JPY 14.77 USD
Previous Close Jan 28
2,262 JPY 14.82 USD
High Jan 29, 2:30 pm
2,267 JPY 14.81 USD
Low Jan 29, 9:05 am
2,233 JPY 14.58 USD
Volume
24,300
Trading Value
0.06B JPY 0.36M USD
VWAP
2254.01 JPY 14.73 USD
Minimum Trading Value
225,600 JPY 1,474 USD
Market Cap
0.02T JPY 0.14B USD
Number of Trades
116
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Mid
1-Year Average
89
1-Year High Feb 10, 2025
818
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 21,900 28,500 1.30
Jan 16, 2026 18,000 27,700 1.54
Jan 9, 2026 15,400 30,400 1.97
Dec 26, 2025 9,400 27,900 2.97
Dec 19, 2025 7,900 23,900 3.03
Company Profile
Fuso Pharmaceutical Industries, Ltd. is a leading manufacturer of artificial kidney dialysis solutions and holds a high market share in blood-related pharmaceuticals. The company also produces medical devices and generic drugs.
Sector
Pharmaceuticals
Fuso Pharmaceutical Industries, Ltd. primarily engages in the manufacture and sale of medical pharmaceuticals and medical equipment. In the field of medical pharmaceuticals, the company focuses on the production and distribution of injectable solutions, particularly infusion fluids, and artificial kidney dialysis agents. Additionally, the company undertakes contract manufacturing of pharmaceuticals and develops generic drugs. Beyond its pharmaceutical operations, Fuso has established a presence in the real estate sector through property leasing. By encompassing a wide range of activities from manufacturing to sales, primarily in the medical field, Fuso has built a diversified revenue structure.